Aligos Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US01626L1052
USD
6.03
-0.34 (-5.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAligos Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-5.34%
-0.38%
1W
0.67%
1.78%
1M
-23.67%
10.89%
YTD
-35.3%
7.18%
1Y
38.3%
30.29%
3Y
386.29%
77.39%
5Y
-99.11%
73.35%
10Y
%
256.67%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.62%
0%
-17.62%
6 Months
-14.71%
0%
-14.71%
1 Year
38.3%
0%
38.3%
2 Years
-69.47%
0%
-69.47%
3 Years
386.29%
0%
386.29%
4 Years
-76.81%
0%
-76.81%
5 Years
-99.11%
0%
-99.11%

Aligos Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary